EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The role of autologous bone grafting in matrix‐associated autologous chondrocyte implantation at the knee: Results from the German Cartilage Registry (KnorpelRegister DGOU)

Johannes Weishorn, Thomas Tischer, Philipp Niemeyer, Tobias Renkawitz, Yannic Bangert

Knee Surgery, Sports Traumatology, Arthroscopy · 2024

DOI: 10.1002/ksa.12106 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Knee Surgery, Sports Traumatology, Arthroscopy, 2024. Verfasst von Johannes Weishorn und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics, Heidelberg University Hospital, Ruprecht-Karls-University Heidelberg, Heidelberg, Germany. Hauptthemen laut MEDLINE: Chondrocytes, Cartilage, Articular. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: None.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To investigate whether concomitant autologous bone grafting adversely affects clinical outcome and graft survival after matrix‐associated autologous chondrocyte implantation (M‐ACI).

Methods

The present study examines registry data of patients who underwent M‐ACI with or without autologous bone grafting for large‐sized chondral or osteochondral defects. Propensity score matching was performed to exclude potential confounders. A total of 215 patients with similar baseline characteristics were identified. Clinical outcome was assessed at the time of surgery and at 6, 12, 24, 36 and 60 months using the Knee Injury and Osteoarthritis Outcome Score (KOOS). KOOS change, clinical response rate, KOOS subcomponents and failure rate were determined.

Results

Patients treated with M‐ACI and autologous bone grafting achieved comparable clinical outcomes compared with M‐ACI alone. At 24 months postoperatively, the patient‐reported outcome (PRO) of patients treated with M‐ACI and autologous bone grafting was even significantly better as measured by KOOS (74.9 ± 18.8 vs. 79.2 ± 15.4; p = 0.043). However, the difference did not exceed the minimal clinically important difference (MCID). In patients with M‐ACI and autologous bone grafting, a greater change in KOOS relative to baseline was observed at 6 (9.3 ± 14.7 vs. 15.0 ± 14.7; p = 0.004) and 12 months (12.6 ± 17.2 vs. 17.7 ± 14.6; p = 0.035). Overall, a high clinical response rate was observed in both groups at 24 months (75.8% vs. 82.0%; p = n.s.). The estimated survival at the endpoint of reoperation for any reason was 82.1% (SD 2.8) at 8.4 years for isolated M‐ACI and 88.7% (SD 2.4) at 8.2 years for M‐ACI with autologous bone grafting ( p = 0.039).

Conclusions

Even in the challenging cohort of large osteochondral defects, the additional treatment with autologous bone grafting leads to remarkably good clinical outcomes in patients treated with M‐ACI. In fact, they tend to benefit more from surgery, have lower revision rates and achieve clinical response rates earlier. Subchondral bone management is critical to the success of M‐ACI and should be addressed in the treatment of borderline defects. Level of Evidence Level III.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChondrocytesCartilage, ArticularHumansBone TransplantationKnee JointTransplantation, AutologousRegistries

Stichwörter der Autor:innen

ACIautologous bone graftingcartilagekneeosteochondral defectsregistry

Autor:innen und Institutionen

  • Department of Orthopaedics, Heidelberg University Hospital, Ruprecht-Karls-University Heidelberg, Heidelberg, Germany.
  • Malteser Waldkrankenhaus St. Marien, Erlangen, Germany.
  • Department of Orthopaecdics, University Medical Center Rostock, Rostock, Germany.
  • OCM Orthopedic Surgery Munich, Munich, Germany.
  • Clinic for Orthopedics and Trauma Surgery, Albert-Ludwigs-University Freiburg, Freiburg im Breisgau, Germany.

Förderung

  • None

Zitieren

APA

Weishorn, J., Tischer, T., Niemeyer, P., Renkawitz, T., & Bangert, Y. (2024). The role of autologous bone grafting in matrix‐associated autologous chondrocyte implantation at the knee: Results from the German Cartilage Registry (KnorpelRegister DGOU). Knee Surgery, Sports Traumatology, Arthroscopy. https://doi.org/10.1002/ksa.12106

Vancouver

Weishorn J, Tischer T, Niemeyer P, Renkawitz T, Bangert Y. The role of autologous bone grafting in matrix‐associated autologous chondrocyte implantation at the knee: Results from the German Cartilage Registry (KnorpelRegister DGOU). Knee Surgery, Sports Traumatology, Arthroscopy. 2024. doi:10.1002/ksa.12106

BibTeX
@article{Weishorn2024,
  author = {Weishorn, Johannes and Tischer, Thomas and Niemeyer, Philipp and Renkawitz, Tobias and Bangert, Yannic},
  title = {The role of autologous bone grafting in matrix‐associated autologous chondrocyte implantation at the knee: Results from the German Cartilage Registry (KnorpelRegister DGOU)},
  journal = {Knee Surgery, Sports Traumatology, Arthroscopy},
  year = {2024},
  doi = {10.1002/ksa.12106}
}
Kostenlos starten →